Molecular Analysis of Human Neural Stem Cells
NCT01329926 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-04-12
Summary
The aim of this study is to develop and optimize methods to isolate, propagate and differentiate adult human neural stem cells from patients with degenerative neurological disorders like Parkinson's disease.
Conditions
- Parkinson's Disease
- Parkinsonism
Interventions
- PROCEDURE
-
Harvesting of neural stem cells
During neurosurgical procedures, tissue samples are obtained along trajectory of implanted electrodes or removal of stimulators previously implanted.
Sponsors & Collaborators
-
NeuroGeneration
lead INDUSTRY
Principal Investigators
-
Michel F Levesque, MD · Los Angeles Neurosurgical Institute
Eligibility
- Min Age
- 35 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2022-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)
NCT02922530 ·Status: WITHDRAWN ·Phase: NA
-
Determining Patterns In Trial Experiences of Parkinson's Disease Patients
NCT05685329 ·Status: NOT_YET_RECRUITING
-
Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease
NCT05699694 ·Status: RECRUITING ·Phase: NA
-
Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
NCT01954875 ·Status: WITHDRAWN
-
Measuring Parkinson's Disease Progression
NCT03205956 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease
NCT01227681 ·Status: TERMINATED ·Phase: PHASE2
-
Biomarker Discovery in Parkinson's Disease
NCT02016092 ·Status: UNKNOWN
-
Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease
NCT04598828 ·Status: TERMINATED ·Phase: NA
-
Clinical Research on Stem Cell Therapy for Parkinson's Disease
NCT07232147 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Genotypic Influences on Network Progression in Parkinson's Disease
NCT04228172 ·Status: ACTIVE_NOT_RECRUITING
-
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
NCT02896816 ·Status: TERMINATED ·Phase: NA
-
Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease
NCT05962476 ·Status: TERMINATED ·Phase: NA
-
Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)
NCT02881099 ·Status: COMPLETED
-
Molecular and Functional Imaging in SNCA, Parkin and PINK1
NCT04084509 ·Status: WITHDRAWN
-
Serum Biomarkers in Parkinson's Disease at Different Stages
NCT05769699 ·Status: RECRUITING ·Phase: NA
-
Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.
NCT05435755 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Transcranial Magnetic Stimulation in Parkinson's Disease
NCT00023062 ·Status: COMPLETED
-
Biomarker Analysis for GBA Associated Parkinson's Disease
NCT03811496 ·Status: UNKNOWN
-
Imaging Biomarkers in Parkinson s Disease
NCT01496599 ·Status: COMPLETED
-
Mutations Associated With Parkinson s Disease
NCT01547832 ·Status: TERMINATED
-
Non-drug Treatment Study in Parkinson's Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers
NCT05837130 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
NCT01106976 ·Status: COMPLETED
-
Deep Brain Stimulation in Patients With Parkinson's Disease
NCT00586079 ·Status: COMPLETED ·Phase: NA
-
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
NCT01759888 ·Status: COMPLETED ·Phase: PHASE2
-
Innovative Biomarkers in de Novo Parkinson's Disease
NCT03940677 ·Status: TERMINATED ·Phase: NA